IRIS Appoints Amin Khalifa as CFO
IRIS International, a global in vitro diagnostics company, has appointed Amin Khalifa as corporate vice president of finance, and as chief financial officer (CFO), effective on the day immediately following the filing by the company of its Form 10-Q for 3Q10. Khalifa has approximately 30 years of senior finance and corporate management experience, having served as CFO of such companies as Apria Healthcare, Beckman Coulter, and Leap Wireless.
Reporting directly to Cesar Garcia, chairman, president and chief executive officer (CEO), Khalifa will oversee the company’s finance, accounting, investor relations and information technology functions. He replaces Martin McDermut, who served as acting CFO from May 2010.
Khalifa, who since 2007 was a management consultant advising venture capital clients and operating companies on acquisitions, strategy and financial matters, was previously executive vice president (EVP) and CFO of Leap Wireless. Prior to Leap, from 2003-2006, he was EVP and CFO of Apria Healthcare, a US home healthcare company with revenues of US$1.5bn. Before that, from 1999-2003, he was vice president and CFO of Beckman Coulter, a US$2bn life science and diagnostics company.
Prior to 1999, Khalifa held several CFO and/or senior executive positions at the agricultural division of Monsanto, the health insurance division of Aetna, Aetna Health Plans, and served for 15 years in various corporate and international capacities with PepsiCo.
Khalifa earned a MBA in Finance and a BSc in Industrial Engineering and Economics from Lehigh University.